Retractable Technologies (Retractable Technologies) Change In Working Capital

: $4.59 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

Retractable Technologies's change in working capital for the quarter that ended in Dec. 2023 was $2.47 Mil.

Retractable Technologies's change in working capital for the fiscal year that ended in Dec. 2023 was $4.59 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Retractable Technologies Change In Working Capital Historical Data

The historical data trend for Retractable Technologies's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

-1.67

0.51

-17.32

-4.92

4.59

Retractable Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital																9.44	-3.44	-0.47	6.03	2.47

Retractable Technologies Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.59 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Retractable Technologies Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Retractable Technologies (Retractable Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.

Executives

Thomas J Shaw	director, 10 percent owner, officer: President and CEO	511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr	director	816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley	director	1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman	director, officer: Vice President of Sales	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii	director, officer: Chief Financial Officer	511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack	director	1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut	director	1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno	10 percent owner	777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August	10 percent owner	340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner	director, officer: Exec. VP, Eng & Prod.	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza	director	P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu	director	511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King	director	9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios	officer: Vice President/General Counsel	511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines

From GuruFocus

Is Retractable Technologies (RVP) Modestly Undervalued? A Comprehensive Analysis

By GuruFocus Research • 08-22-2023

Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares

By gurufocus • 03-16-2009